Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iNetworks Opportunity Fund II Advisors is a U.S.-based investment management entity within the iNetworks family of funds. The firm operates as a venture capital/private equity advisor and general partner, investing in healthcare, life sciences, and information technology companies rather than developing therapeutic products itself. Public descriptions of the firm emphasize operational support, growth capital, and strategic guidance for portfolio companies. Available evidence indicates it has been active since 1999 as part of the broader iNetworks platform and is based in the Pittsburgh, Pennsylvania area. Because it is an investment firm rather than a drug developer, it does not have a clinical pipeline, therapeutic targets, or product-stage programs of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iNetworks Opportunity Fund II Advisors.